Ulrika Andersson

Director, Drug Development

Ulrika Andersson is Director of Drug Development at Cytel and has worked across all stages of product development, ranging from ​preclinical formulation development to ​commercial production. Throughout her career, she has focused on project management, commercial management, and cross-functional ways of working in a global environment. She draws on more than 25 years of experience in the pharmaceutical industry to ensure sustainable business relationships with our customers.

Ulrika holds a master’s degree in Pharmacy from Uppsala University.